Development of Bioartificial Myocardium Using Stem Cells and Nanobiotechnology Templates

الملخص EN

Cell-based regenerative therapy is undergoing experimental and clinical trials in cardiology, in order to limit the consequences of decreased contractile function and compliance of damaged ventricles following myocardial infarction.

Over 1000 patients have been treated worldwide with cell-based procedures for myocardial regeneration.

Cellular cardiomyoplasty seems to reduce the size and fibrosis of infarct scars, limit adverse postischemic remodelling, and improve diastolic function.

The development of a bioartificial myocardium is a new challenge; in this approach, tissue-engineered procedures are associated with cell therapy.

Organ decellularization for bioscaffolds fabrication is a new investigated concept.

Nanomaterials are emerging as the main candidates to ensure the achievement of a proper instructive cellular niche with good drug release/administration properties.

Investigating the electrophysiological properties of bioartificial myocardium is the challenging objective of future research, associating a multielectrode network to provide electrical stimulation could improve the coupling of grafted cells and scaffolds with host cardiomyocytes.

In summary, until now stem cell transplantation has not achieved clear hemodynamic benefits for myocardial diseases.

Supported by relevant scientific background, the development of myocardial tissue engineering may constitute a new avenue and hope for the treatment of myocardial diseases.